Global Intra-uterine Contraceptive Devices (IUCD) Market, 2017-2024 - Increasing Demand for Generic and Biosimilar Drugs
DUBLIN, October 20, 2017 /PRNewswire/ --
The "Global IUCD Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024" report has been added to Research and Markets' offering.
In this region, global intra-uterine contraceptive devices market is projected to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in the forecast period 2017 to 2024.
The global intra-uterine contraceptive devices market is segmented on the basis of product type, end user, and geography.
The global intra-uterine contraceptive devices market is segmented into 2 product types, namely copper IUCD and hormonal IUCD.
On the basis of end users the market is segmented into hospitals, gynaecology clinics, and community healthcare. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.
Market Overview
Drivers
- Rising Cases of Chronic Diseases
- Rising Demand of Self-Injection Devices
- Growth of Biologics Market
- Technological Advancements and Innovations in Drug Delivery Market
Restraints
- Needlestick Injuries and Infections
- High Cost of Development
- Strict Regulatory Framework
Opportunity
- Increasing Demand for Generic and Biosimilar Drugs
- Generics
- Biosimilars
- Increasing Demand for Contraceptive Injectables
- Increasing Demand for Self-Administration of Drugs
Challenges
- Alternative Route of Drug Administration
- Product Recall
- Stability of Products
- Sterility of Injections
Global intra-uterine contraceptive devices (IUCD) market competition by top players including:
Bayer AG dominated the IUCD market accounting largest market share followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. along with others such as include:
- DKT International
- Egemen International
- Melbea AG
- Ocon Medical Ltd.
- Pregna International Limited
- Medical Engineering Corporation SA
- SMB Corporation and Meril Life Sciences Pvt. Ltd.
- Medu Scientific Ltd, China RH Contraceptives Co., Ltd
- Sanghai Jolly Medical Education Co., Ltd
- Bernstein Leibhard LLP
- Zheijang Daji Medical Instruments, Ltd.
- Nimble International
- AME Line, Technico
- Cepeo
- Contraceptivos
- Injeflex Ind And Com Ltda
- Bersil
- Amed.
Key Topics Covered:
1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global Injectable Drug Delivery Market, Regulatory
7. Global Injectable Drug Delivery Market, by Type
8. Global Injectable Drug Delivery Market, by Application
9. Global Injectable Drug Delivery Market, by Usage Pattern
10. Global Injectable Drug Delivery Market, by Mode of Administration
11. Global Injectable Drug Delivery Market, by End User
12. Global Injectable Drug Delivery Market, by Distribution Channel
13. Global Injectable Drug Delivery Market, by Geography
14. Global Injectable Drug Delivery Market, Company Share
15. Company Profiles
- AME Line, Technico
- Amed.
- Bayer AG
- Bernstein Leibhard LLP
- Bersil
- Cepeo
- Contraceptivos
- Egemen International
- Injeflex Ind And Com Ltda
- KT International
- Medical Engineering Corporation SA
- Medu Scientific Ltd, China RH Contraceptives Co., Ltd
- Melbea AG
- Mona Lisa N.V.
- Nimble International
- Ocon Medical Ltd.
- Pregna International Limited
- Sanghai Jolly Medical Education Co., Ltd
- SMB Corporation and Meril Life Sciences Pvt. Ltd.
- Teva Pharmaceuticals Industries Ltd.
- Zheijang Daji Medical Instruments, Ltd.
For more information about this report visit https://www.researchandmarkets.com/research/v5l825/global_iucd
Media Contact:
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article